Loading...
Adenosine metabolism pathway alterations in frontal cortical neurons in schizophrenia
Date
2024
Abstract
Schizophrenia is a neuropsychiatric illness characterized by altered neurotransmission, in which adenosine, a modulator of glutamate and dopamine, plays a critical role that is relatively unexplored in the human brain. In the present study, postmortem human brain tissue from the anterior cingulate cortex (ACC) of individuals with schizophrenia (n = 20) and sex- and age-matched control subjects without psychiatric illness (n = 20) was obtained from the Bronx–Mount Sinai NIH Brain and Tissue Repository. Enriched populations of ACC pyramidal neurons were isolated using laser microdissection (LMD). The mRNA expression levels of six key adenosine pathway components—adenosine kinase (ADK), equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2), ectonucleoside triphosphate diphosphohydrolases 1 and 3 (ENTPD1 and ENTPD3), and ecto-5′ -nucleotidase (NT5E)—were quantified using real-time PCR (qPCR) in neurons from these individuals. No significant mRNA expression differences were observed between the schizophrenia and control groups (p > 0.05). However, a significant sex difference was found in ADK mRNA expression, with higher levels in male compared with female subjects (Mann–Whitney U = 86; p 0.05). The observed sex-specific variations and intercomponent correlations highlight the value of investigating sex differences in disease and contribute to the molecular basis of schizophrenia’s pathology.
Supervisor
Description
Publisher
MDPI
Citation
Cells 2024, 13(19), 1657
Collections
Files
Funding code
Funding Information
This research was funded by the National Institute of Mental Health (MH107487) and the American Foundation for Suicide Prevention (YIG-1-139-20)